Mold-Tek Packaging Limited — Investor Meet, 04-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Mold-Tek Packaging's Q2 saw sales up 9.65% and volumes up 7%, with H1 EBITDA margin at ₹40.6/kg. Pharma sales surged 45% to over ₹10 Cr in Q2, targeting ₹35 Cr+ for FY26, driven by EV tubes, caps, and bottles. Food & FMCG volumes grew 19% with the Panipat plant starting. The paint segment was muted due to heavy rains, though Grasim sales grew 16-17%. Management expects Q4 to rebound strongly, driven by pharma and North India F&F. Full-year volume growth target is 12%, with EBITDA per kg expected at ₹40.7-₹41. FY26 CAPEX is projected at ₹100-₹105 Cr, including new pharma land.